AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients (Q34734053)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

main subject

rituximab

1 reference

based on heuristic

inferred from title

author name string

Antonio J Grillo-López

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

publication date

1 June 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

published in

Expert Review of Anticancer Therapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

volume

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

page(s)

323-329

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

cites work

Non-Hodgkin's lymphoma: review of conventional treatments

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.2.3.323

retrieved

21 January 2018

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.2.3.323

retrieved

21 January 2018

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.2.3.323

retrieved

21 January 2018

Identifiers

DOI

10.1586/14737140.2.3.323

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

Fatcat ID

release_k6mksm7qdzgppme4o2km75ixvi

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/k6mksm7qdzgppme4o2km75ixvi

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

12113055

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12113055

retrieved

4 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34734053&oldid=1973152277"